AtriCure (ATRC) Misses Q4 EPS by 13c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- S&P 500, Dow set for lower open after jobs report fuels rate-hike bets
- US nonfarm payrolls surge in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil heads for weekly gain as US-Iran fighting resumes; diesel hits record high
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
AtriCure Inc. (ATRC) PT Raised to $57 at BTIG
February 13, 2025 5:21 AM ESTBTIG analyst Marie Thibault raised the price target on AtriCure Inc. (NASDAQ: ATRC) to $57.00 (from $53.00) while maintaining a Buy rating.
The analyst comments "AtriCure announced Q4 revenue of $124.3M (+16.6% y/y rep, +16.7% y/y cc), in line with the preliminary announcement last month. This result came in above the implied Q4 guidance range of $118M-$121M, beating consensus and our forecast of $119.8M at the time of the pre-announcement. U.S.... More
